Selvaratnam et al describe a retrospective cohort study, which demonstrated that public reporting of an indicator of screening performance for term fetal growth restriction (FGR) was associated with an accelerated reduction in stillbirth rate (BJOG xxxx). The reduction was most marked in stillbirths with a birth weight <3rd percentile, which supports a causal association. However, the welcome reduction in stillbirth occurred at the cost of increasing rates of iatrogenic neonatal morbidity. The association with increased morbidity most likely reflects the fact that the primary disease modifying intervention to prevent stillbirth is medically indicated delivery.